Oxidant and antioxidant parameters in prediabetes and diabetes
dc.contributor.author | Erdem, Said Sami | |
dc.contributor.author | Toker, Aysun | |
dc.contributor.author | Kayrak, Mehmet | |
dc.contributor.author | Cicekler, Humeyra | |
dc.contributor.author | Gonulalan, Gulsum | |
dc.contributor.author | Abdulhalikov, Turyan | |
dc.contributor.author | Yerlikaya, Fatma Humeyra | |
dc.date.accessioned | 2024-02-23T14:00:08Z | |
dc.date.available | 2024-02-23T14:00:08Z | |
dc.date.issued | 2015 | |
dc.department | NEÜ | en_US |
dc.description.abstract | The aim of our study was to evaluate serum paraoxonase (PON1), total antioxidant status (TAS), total oxidant status (TOS), and ischemia-modified albumin (IMA) levels in patients with prediabetes, diabetes, and in healthy control subjects. The subjects were aged between 20 and 60 years. Forty diabetic subjects (mean age 46.6 +/- 9.7 years), 39 prediabetic subjects (mean age 44.0 +/- 9.3 years) and 24 healthy control subjects (mean age 43.7 +/- 9.7 years). Lipid profile, PON1, TAS, TOS and IMA levels were measured. The serum TOS and IMA levels in diabetes were significantly higher than those of the control subjects (P=0.024 and P=0.012, respectively), while the serum PON1 levels of the diabetes patients were significantly lower than those of the control subjects (P=0.039). The serum TOS levels of the diabetes patients were significantly higher than those of the subjects with prediabetes (P=0.013). There were no significant differences between the serum IMA and PON1 levels of the prediabetes and diabetes groups (P=0.075 and P=0.110, respectively). The serum TAS levels of the three groups were similar. The present study demonstrated that in diabetes there is greater oxidative stress. Patients with type 2 diabetes had higher TOS and IMA levels, but lower PON1 values, than controls. There were no differences in oxidative stress markers between prediabetic patients and healthy subjects. | en_US |
dc.identifier.doi | 10.1007/s13410-013-0185-4 | |
dc.identifier.endpage | S470 | en_US |
dc.identifier.issn | 0973-3930 | |
dc.identifier.issn | 1998-3832 | |
dc.identifier.scopus | 2-s2.0-84953250730 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | S465 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s13410-013-0185-4 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/11456 | |
dc.identifier.volume | 35 | en_US |
dc.identifier.wos | WOS:000411020700030 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer India | en_US |
dc.relation.ispartof | International Journal Of Diabetes In Developing Countries | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Total Antioxidant Status | en_US |
dc.subject | Total Oxidant Status | en_US |
dc.subject | Ischemia-Modified Albumin | en_US |
dc.subject | Paraoxonase | en_US |
dc.subject | Prediabetes | en_US |
dc.title | Oxidant and antioxidant parameters in prediabetes and diabetes | en_US |
dc.type | Article | en_US |